BIBLIOGRAPHIC RECORD

Empagliflozin as an Alternative to Metformin for Antipsychotic‐Related Weight Gain: Double‐Blind Randomized Controlled Trial

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors: Atena Dolati; Davoud Ahmadimoghaddam; Maryam Zamanirafe; Shabnam Rezaie; Salman Khazaie; Maryam Mehrpooya; Mona Doostizadeh
Source of metadata: Crossref
Year recorded: 2026

Public identifiers and source

doi:10.1002/hup.70047

Open the source record

Reference

Atena Dolati; Davoud Ahmadimoghaddam; Maryam Zamanirafe; Shabnam Rezaie; Salman Khazaie; Maryam Mehrpooya; Mona Doostizadeh. (2026). Empagliflozin as an Alternative to Metformin for Antipsychotic‐Related Weight Gain: Double‐Blind Randomized Controlled Trial. https://doi.org/10.1002/hup.70047

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-5d84d691f60d2f3c74cd2ae720995bde/